Published: Jan. 15, 2026 at 11:51\u202fa.m. ET<\/p>\n
Millions of Americans have tried GLP-1s, but some people find that the weight-loss drugs have too many side effects, are expensive or just don\u2019t work for them.<\/p>\n
Patients also have to deal with changes to their health insurance at the start of a new year, and more employers have withdrawn coverage of the pricey medications. About half of the people who stop taking GLP-1s, like Eli Lilly\u2019s LLY<\/a> Zepbound or Novo Nordisk\u2019s NVO<\/a> Wegovy, discover that they gain back all the weight they lost within two years.<\/p>\n","protected":false},"excerpt":{"rendered":"Published: Jan. 15, 2026 at 11:51\u202fa.m. ET Millions of Americans have tried GLP-1s, but some people find that…\n","protected":false},"author":2,"featured_media":286264,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[143489,82826,18,27036,41579,3334,49758,135,475,19,17,3521,6403,82656,94542,14965,462,69291,143487,143488,2927,2900,7840,87959,9436,44285,26243,5359,642,9384,143490,101159,46210],"class_list":{"0":"post-286263","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-boston-scientific-corp","9":"tag-bsx","10":"tag-eire","11":"tag-eli-lilly-co","12":"tag-gcapi","13":"tag-general-news","14":"tag-glp1","15":"tag-health","16":"tag-health-care","17":"tag-ie","18":"tag-ireland","19":"tag-lifestyle","20":"tag-living","21":"tag-living-lifestyle","22":"tag-lly","23":"tag-manufacturing","24":"tag-medication","25":"tag-mental-fitness","26":"tag-novo-nordisk-a-s-adr","27":"tag-nvo","28":"tag-ozempic","29":"tag-pharmaceuticals","30":"tag-physical","31":"tag-physical-mental-fitness","32":"tag-political","33":"tag-political-general-news","34":"tag-synd","35":"tag-wegovy","36":"tag-weight-management","37":"tag-weightloss","38":"tag-ww","39":"tag-ww-international-inc","40":"tag-zepbound"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/286263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=286263"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/286263\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/286264"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=286263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=286263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=286263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}